Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review | Synapse
May 16, 2026Endocrine Journal0 citationsOpen Access
Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review
To evaluate the efficacy of I-MIBG therapy in treating metastatic pheochromocytoma associated with MEN2A.
Case report analysis showcasing iodine-131-metaiodobenzylguanidine therapy.
Literature review of existing cases and outcomes.
I-MIBG therapy shows promising efficacy but is based on limited case reports.
Further assessment is necessary to confirm effectiveness due to the rarity of cases.
Abstract
I-MIBG therapy appears promising, its efficacy requires further assessment due to the limited number of reported cases of MEN2A-associated metastatic pheochromocytoma.